Cyber security company Sophos - which has just posted a 16% growth in billings - is to buy US software company Invincea for up to $120 million.
The Abingdon-based listed company will buy Invincea, a developer of patented advanced next-generation malware protection, for $100m in cash on closing of the deal plus up to $20m for an earn-out related to growth achieved during the first year of ownership.
Invincea Labs, a division of Invincea that has been separately managed and operated since 2010, will be de-merged prior to the acquisition and is not part of the deal.
The deal is subject to regulatory approval and is expected to complete by the end of the current financial year. It is also expected to be broadly neutral to cash earnings before interest, tax, depreciation and amortisation (EBITDA) in its first full year of ownership and thereafter.
Sophos said that the acquisition would extend and consolidate its lead in the growing endpoint cyber security market, and would be complementary to the Intercept X solution that Sophos had already launched.
As interest in the awards remains high, we’ve decided to extend the time left to…
Welcome to the third episode of The Business Magazine Property Podcast, in partnership with MSP…
Farnborough-based Gama Aviation has announced a tie up with Australian outfit Department 13 to mitigate…
Heathrow Airport has reported record-breaking passenger numbers for the first quarter of 2024, A total…
Liquid biopsy company ANGLE has signed a supplier agreement with AstraZeneca. The Guildford firm has…
Thames Valley law firm Blandy & Blandy, which has offices in Reading, Henley-on-Thames and Wokingham,…